Semaglutide Itching: How to Tell What's Causing It

Localised itching at the injection site: the most common picture

Most people who notice itching during semaglutide treatment are reacting to the injection itself rather than to the medicine systemically. The subcutaneous needle creates a small wound, and the surrounding tissue can respond with redness, mild swelling and an itch that fades within a day or two. Rotating your injection site (abdomen, thigh and upper arm are all suitable) reduces the chance of repeated irritation in one spot. Keeping the pen in the fridge door and taking it out a few minutes before your injection, so it reaches room temperature, can also reduce the sting and localised response that some people find triggers itching.

Injection-site technique matters too. Pinching the skin gently, inserting at the correct angle and allowing the needle to fully retract before removing the pen all help minimise trauma. If the itching at the site is mild, passes quickly and doesn't spread, it is generally considered a normal localised response. That said, if the same site is repeatedly uncomfortable, your prescriber can advise on rotation patterns and whether anything in your technique is worth adjusting.

For a broader look at how the medicine works and what the full side-effect profile looks like, the semaglutide overview covers the mechanism alongside the licensed UK use.

Generalised itching and the allergy question

Itching that spreads beyond the injection site raises a different set of considerations. Semaglutide, like any medicine, carries a risk of hypersensitivity reactions. These range from mild urticaria (raised, itchy welts on the skin) to anaphylaxis, which is a severe systemic allergic reaction requiring emergency treatment. The NHS guidance on semaglutide is clear that signs of a serious allergic reaction include a skin rash that may include itchy, red, swollen, blistered or peeling skin; wheezing; tightness in the chest or throat; difficulty breathing or swallowing; swollen mouth, face, lips, tongue or throat.

If you experience any of these alongside itching, do not wait to see whether it settles. Call 999 or go to your nearest A&E. This is not a situation for self-monitoring. Mild, isolated generalised itching without any of these features is less immediately alarming, but it still warrants a call to your prescriber the same day so they can assess whether to continue, pause or switch treatment. The decision about what to do next belongs with the clinician who can see the full picture.

People sometimes ask whether similar symptoms appear with other medicines in this class. The Wegovy treatment page covers the licensed UK product that contains semaglutide, and this page looks specifically at whether semaglutide causes itching in more detail.

Other skin changes during semaglutide treatment worth knowing about

Beyond injection-site reactions and hypersensitivity, a handful of other skin-related changes have been reported during GLP-1 treatment, though the evidence on their frequency is still developing. Rapid weight loss of any kind can cause changes in skin texture and, occasionally, increased sensitivity or dryness that people describe as itching, and our guide to semaglutide and itchy skin explores these patterns in more detail. This is not specific to semaglutide, it reflects the physiological adjustment to a significantly lower calorie intake and the body redistributing fat stores.

There is also a separate, less common consideration for people living with type 2 diabetes on semaglutide: changes in blood glucose can occasionally affect small blood vessels in the eye early in treatment. While eye twitching and visual changes are distinct from itching, some readers searching this topic are concerned about a cluster of new physical symptoms and wondering how they connect. The page on whether Wegovy can cause eye twitching addresses that question separately.

If you are considering starting semaglutide and want to understand the side-effect profile before committing, the weight-loss treatments overview sets out what the current licensed options in the UK involve. You can also read more about the itchiness question specifically if you're trying to work out whether what you're experiencing is typical.

When to act, and how a prescriber can help

The practical decision this page is built around is a simple one: is the itching you're experiencing something to monitor, something to discuss at your next check-in, or something that needs attention today? Severe or spreading itching with any of the allergic features described above means today, right now, 999 or A&E. Mild, localised, short-lived site reactions mean monitor and mention at your next review. Anything in between (generalised but mild, or persistent beyond two to three days) means contact your prescriber before your next scheduled dose.

At nume, a real prescriber reviews every patient's case; it does not go to an automated system. If you're concerned about a new symptom, the contact page explains how to reach the clinical team, and urgent aftercare is available seven days a week. Suspected side effects from any medicine can also be reported directly to the MHRA via the Yellow Card scheme, which helps build the national evidence base on how medicines behave in real-world use.

If you'd like a prescriber to review whether semaglutide is right for you, or to discuss a symptom you're experiencing during treatment, you're welcome to speak to our prescribers through a free consultation.